| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 114,774 | 167,400 | 255,208 | | Cost of Revenue | 65,413 | 104,927 | 173,974 | | | Gross Profit | 49,361 | 62,473 | 81,234 | | | Operating Expenses | | Research Development | 26,929 | 39,804 | 56,573 | | Selling General and Administrative | 34,995 | 57,351 | 61,325 | | Non Recurring | 23,039 | 2,902 | 18,411 | | Others | 758 | 2,893 | 5,996 | | | | Total Operating Expenses | 85,721 | 102,950 | 142,305 | | | | Operating Income or Loss | (36,360) | (40,477) | (61,071) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,008 | 31,335 | 25,618 | | Earnings Before Interest And Taxes | (15,352) | (9,142) | (35,453) | | Interest Expense | 1,229 | 3,646 | 3,405 | | Income Before Tax | (16,581) | (12,788) | (38,858) | | Income Tax Expense | (2,605) | (2,694) | (63,704) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,976) | (10,094) | 24,846 | | | Non-recurring Events | | Discontinued Operations | 3,786 | 479 | 5,997 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,190) | (9,615) | 30,843 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,190) | ($9,615) | $30,843 |
|
0.25% Nasdaq 
0.0184 (0.58%) 
Income Statement
